Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia

BACKGROUND: Schizophrenia is associated with a lowered life expectancy due to cardiovascular disease. This is, at least in part, related to an increased vulnerability to the development of metabolic syndrome (MetS) in patients with schizophrenia. The dysregulation of apolipoproteins (Apos) may also...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Heliyon
Asıl Yazarlar: Boiko, Anastasiia S., Mednova, Irina A., Kornetova, Elena G., Semke, Arkadiy V., Bokhan, Nikolay A., Loonen, Anton J.M., Ivanova, Svetlana A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6611937/
https://ncbi.nlm.nih.gov/pubmed/31317083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.heliyon.2019.e02033
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller